Du Jianguo, Luan Jing, Liu Hua, Daniel Thomas O, Peiper Stephen, Chen Theresa S, Yu Yingchun, Horton Linda W, Nanney Lillian B, Strieter Robert M, Richmond Ann
Department of Veterans Affairs and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
J Leukoc Biol. 2002 Jan;71(1):141-53.
CXC chemokines, which induce angiogenesis, have glutamine-leucine-arginine amino acid residues (ELR motif) in the amino terminus and bind CXCR2 and the Duffy antigen chemokine-binding protein. Duffy, a seven transmembrane protein that binds CXC and CC chemokines, has not been shown to couple to trimeric G proteins or to transduce intracellular signals, although it is highly expressed on red blood cells, endothelial cells undergoing neovascularization, and neuronal cells. The binding of chemokines by Duffy could modulate chemokine responses positively or negatively. Positive regulation could come through the presentation of chemokine to functional receptors, and negative regulation could come through Duffy competition with functional chemokine receptors for chemokine binding, thus serving as a decoy receptor. To determine whether Duffy has a role in angiogenesis and/or maintenance of homeostasis, we developed transgenic mice expressing mDuffy under the control of the preproendothelin promoter/enhancer (PPEP), which directs expression of the transgene to the endothelium. Two PPEP-mDuffy-transgenic founders were identified, and expression of the transgene in the endothelium was verified by Northern blot, RT-PCR, and immunostaining of tissues. The phenotype of the mice carrying the transgene appeared normal by all visual parameters. However, careful comparison of transgenic and nontransgenic mice revealed two phenotypic differences: mDuffy-transgenic mice exhibited a diminished angiogenic response to MIP-2 in the corneal micropocket assay, and mDuffy-transgenic mice exhibited enhanced hepatocellular toxicity and necrosis as compared with nontransgenic littermates in response to overdose of acetaminophen (APAP; 400 mg/kg body weight). Morover, APAP treatment was lethal in 50% of the mDuffy-transgenic mice 24 h post challenge, and 100% of the nontransgenic littermates survived this treatment at the 24 h time point. Our data suggest that enhanced expression of mDuffy on endothelial cells can lead to impaired angiogenic response to chemokines and impaired maintenance of homeostasis in response to toxic stresses.
CXC趋化因子可诱导血管生成,其氨基末端具有谷氨酰胺 - 亮氨酸 - 精氨酸氨基酸残基(ELR基序),并与CXCR2和达菲抗原趋化因子结合蛋白结合。达菲是一种结合CXC和CC趋化因子的七跨膜蛋白,尽管它在红细胞、正在进行新血管形成的内皮细胞和神经元细胞上高度表达,但尚未显示其与三聚体G蛋白偶联或转导细胞内信号。达菲与趋化因子的结合可以正向或负向调节趋化因子反应。正向调节可能通过将趋化因子呈递给功能性受体来实现,而负向调节可能通过达菲与功能性趋化因子受体竞争趋化因子结合来实现,从而充当诱饵受体。为了确定达菲在血管生成和/或内环境稳态维持中是否起作用,我们构建了在人前内皮素启动子/增强子(PPEP)控制下表达mDuffy的转基因小鼠,该启动子/增强子将转基因的表达导向内皮细胞。鉴定出两个PPEP - mDuffy转基因奠基者,并通过Northern印迹、RT - PCR和组织免疫染色验证了转基因在内皮细胞中的表达。通过所有视觉参数观察,携带转基因的小鼠表型看起来正常。然而,对转基因小鼠和非转基因小鼠的仔细比较揭示了两个表型差异:在角膜微袋试验中,mDuffy转基因小鼠对MIP - 2的血管生成反应减弱;与非转基因同窝小鼠相比,mDuffy转基因小鼠在对乙酰氨基酚(APAP;400 mg/kg体重)过量反应时表现出增强的肝细胞毒性和坏死。此外,在攻击后24小时,50%的mDuffy转基因小鼠因APAP治疗而死亡,而在24小时时间点,100%的非转基因同窝小鼠在这种治疗下存活。我们的数据表明,内皮细胞上mDuffy表达的增强可导致对趋化因子的血管生成反应受损以及对毒性应激的内环境稳态维持受损。